Sfs Group (LTS:0OAF) Research & Development: € Mil (TTM As of . 20)


What is Sfs Group Research & Development?

Sfs Group LTS:0OAF Research & Development is € Mil as of . 20.

Research & Development is the aggregate amount of research and development expenses during the year. Sfs Group's Research & Development for the three months ended in . 20 was €0.00 Mil. Sfs Group does not have enough years/quarters to calculate the Research & Development for the trailing twelve months (TTM) ended in . 20.

Sfs Group  (LTS:0OAF) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Sfs Group Research & Development Related Terms

Sfs Group Research & Development Historical Data

* Premium members only.

The historical data trend for Sfs Group's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sfs Group Research & Development Chart

Sfs Group Annual Data
Trend
Research & Development

Sfs Group Quarterly Data
Research & Development

Sfs Group Research & Development Calculation

This is the expense the company spent on research and development.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of € Mil mean?
Sfs Group (LTS:0OAF) has a Research & Development of € Mil as of . 20. Research and development expense is the total cost for research and development activities. View historical data on Sfs Group and its competitors.
Is Sfs Group's Research & Development too high?
Sfs Group's current Research & Development is € Mil.
How does Sfs Group's Research & Development compare to UMAX and MUSS?
Sfs Group's Research & Development of € Mil can be compared against companies in the Conglomerates industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Conglomerates company?
A good Research & Development depends on the Conglomerates industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Sfs Group and its competitors. Sfs Group's current Research & Development is € Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sfs Group stock overvalued right now?
Sfs Group (LTS:0OAF) has a current Research & Development of € Mil. The current Research & Development is € Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Sfs Group (LTS:0OAF), the current Research & Development is € Mil as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Sfs Group Business Description

Address 6 Theotoki Street, PO Box 22379, Ellinas House, Nicosia, CYP, 1521
Sfs Group provides financial and consulting services in Cyprus, the United States, and Europe. The company is engaged in shipping, real estate, capital markets and private equity. Its capital market business comprises of Investment Banking, Asset Management, Wealth Management and Money Transfers.